Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Biochemical Journal

• Publication date

  2004-01-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ20031207PMID 14556646PMCID PMC1223877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation.

  2009cited by this paper
• Salicylic Acid Reverses Phorbol 12-Myristate-13-Acetate (PMA)- and Tumor Necrosis Factor α (TNFα)-induced Insulin Receptor Substrate 1 (IRS1) Serine 307 Phosphorylation and Insulin Resistance in Human Embryonic Kidney 293 (HEK293) Cells*

  2003cited by this paper
• Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression.

  2003cited by this paper
• Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury.

  2002cited by this paper
• Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle*

  2002cited by this paper
• Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action*

  2002cited by this paper
• A central role for JNK in obesity and insulin resistance

  2002cited by this paper
• The mechanisms of action of PPARs.

  2002cited by this paper
• Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.

  2002cited by this paper
• IRS proteins and the common path to diabetes.

  2002cited by this paper
• Fatty Acid Infusion Selectively Impairs Insulin Action on Akt1 and Protein Kinase C λ/ζ but Not on Glycogen Synthase Kinase-3*

  2002cited by this paper
• Role of Akt/protein kinase B in metabolism.

  2002cited by this paper
• Pi 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes.

  2002cited by this paper
• Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes.

  2002cited by this paper
• Cbl, IRS-1, and IRS-2 Mediate Effects of Rosiglitazone on PI3K, PKC-λ, and Glucose Transport in 3T3/L1 Adipocytes.

  2002cited by this paper
• Amino acid- and lipid-induced insulin resistance in rat heart: molecular mechanisms.

  2002cited by this paper
• Cbl, IRS-1, and IRS-2 mediate effects of rosiglitazone on PI3K, PKC-lambda, and glucose transport in 3T3/L1 adipocytes.

  2002cited by this paper
• Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists.

  2002cited by this paper
• Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ

  2001cited by this paper
• Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.

  2001cited by this paper
• Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes.

  2001cited by this paper
• Prevention of fat-induced insulin resistance by salicylate.

  2001cited by this paper
• Thiazolidinediones (PPARγ agonists) but not PPAR α agonists increase IRS‐2 gene expression in 3T3‐L1 and human adipocytes 1

  2001cited by this paper
• Protein Kinase C-ζ Phosphorylates Insulin Receptor Substrate-1 and Impairs Its Ability to Activate Phosphatidylinositol 3-Kinase in Response to Insulin*

  2001cited by this paper
• Mammalian Target of Rapamycin Pathway Regulates Insulin Signaling via Subcellular Redistribution of Insulin Receptor Substrate 1 and Integrates Nutritional Signals and Metabolic Signals of Insulin

  2001cited by this paper
• Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways.

  2001cited by this paper
• Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms β2 and θ

  2000cited by this paper
• Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats.

  2000cited by this paper
• Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta2 and theta.

  2000cited by this paper
• The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 *

  2000cited by this paper
• Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.

  2000cited by this paper
• Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.

  2000cited by this paper
• Exercise and thiazolidinedione therapy normalize insulin action in the obese Zucker fatty rat.

  2000cited by this paper
• Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.

  2000cited by this paper
• Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists

  2000cited by this paper
• Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.

  1999cited by this paper
• Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.

  1999cited by this paper
• Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects*

  1999cited by this paper
• Signaling Mechanisms That Regulate Glucose Transport*

  1999cited by this paper
• Hyperglycemia impairs the insulin signaling step between PI 3-kinase and Akt/PKB activations in ZDF rat liver.

  1999cited by this paper
• Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes.

  1999cited by this paper
• Interaction of insulin receptor substrate-1 (IRS-1) with phosphatidylinositol 3-kinase: effect of substitution of serine for alanine in potential IRS-1 serine phosphorylation sites.

  1998cited by this paper
• Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene.

  1998cited by this paper
• Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

  1998cited by this paper
• Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.

  1997cited by this paper
• Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.

  1996cited by this paper
• Phosphorylation of Insulin Receptor Substrate-1 on Multiple Serine Residues, 612, 632, 662, and 731, Modulates Insulin Action (*)

  1996cited by this paper
• Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats.

  1996cited by this paper
• Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

  1996cited by this paper
• Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1.

  1995cited by this paper
• Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes.

  1994cited by this paper
• Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling.

  1994cited by this paper
• Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity.

  1988cited by this paper
• Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity.

  1986cited by this paper

• Integrated Bioinformatics and Pharmacogenomic Profiling of a Gene Panel in Diabetes Mellitus Treatment Response

  2025cites this paper
• Triple-action of the standardized antidiabetic polyherbal extract; Synacinn™ through upregulation of GLUT4 and inhibition of DPP(IV), α-amylase, and α-glucosidase activity.

  2022cites this paper
• Towards an Insulin Resistant Adipose Model on a Chip

  2020cites this paper
• Serine Phosphorylation of IRS1 Correlates with Aβ-Unrelated Memory Deficits and Elevation in Aβ Level Prior to the Onset of Memory Decline in AD

  2019cites this paper
• Insulin resistance in 3T3-L1 adipocytes by TNF-α is improved by punicic acid through upregulation of insulin signalling pathway and endocrine function, and downregulation of proinflammatory cytokines.

  2018cites this paper
• Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro

  2017cites this paper
• Pharmacological evaluation of combination of plant steroids and low dose Glucocorticoid for treatment of inflammatory disorders in experimental animals

  2017cites this paper
• Developmental Programming: Prenatal Testosterone Excess and Insulin Signaling Disruptions in Female Sheep

  2016cites this paper
• Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.

  2016cites this paper
• Screening of Microbial Extracts for Anticancer Compounds Using Streptomyces Kinase Inhibitor Assay

  2015cites this paper
• Insulin response dysregulation explains abnormal fat storage and increased risk of diabetes mellitus type 2 in Cohen Syndrome.

  2015cites this paper
• Insulin and Metabolic Stress Stimulate Multisite Serine/Threonine Phosphorylation of Insulin Receptor Substrate 1 and Inhibit Tyrosine Phosphorylation*

  2014cites this paper
• AS-30D hepatoma as a model to study on insulin resistance in vitro.

  2013cites this paper
• Phosphorylated S6K1 (Thr389) is a molecular adipose tissue marker of altered glucose tolerance.

  2013cites this paper
• Insulin signalling mechanisms for triacylglycerol storage

  2013cites this paper
• Identification of TRPV4 as a Regulator of Adipose Oxidative Metabolism, Inflammation and Energy Homeostasis by a Chemical Biology Approach

  2013cites this paper
• Mechanisms of Obesity-Induced Inflammation and Insulin Resistance: Insights into the Emerging Role of Nutritional Strategies

  2013cites this paper
• Insulin receptor and IRS-1 co-immunoprecipitation with SOCS-3, and IKKα/β phosphorylation are increased in obese Zucker rat skeletal muscle.

  2012cites this paper
• Functional interactions between peroxisome proliferator-activated receptor-gamma and polipoprotein E isoforms in the regulation of neural functions in models of insulin resistance-relevance to Alzheimer's disease

  2012influential citation
• p38 Mitogen-Activated Protein Kinase-Dependent Transactivation of ErbB Receptor Family

  2011cites this paper
• Stimulation of Glucose Uptake and Improvement of Insulin Resistance by Aromadendrin

  2011cites this paper
• Effects of Peroxisome Proliferator-Activated Receptor Ligands on the Hypothalamic-Pituitary-Gonadal Axis of the Male Goldfish

  2011cites this paper
• Suppression of vascular endothelial growth factor (VEGF) induced angiogenic responses by fucodiphloroethol G

  2011cites this paper
• Insulin Signaling in Normal and Diabetic Conditions

  2010cites this paper
• Peroxisome Proliferator-Activated Receptor α Agonism Prevents Renal Damage and the Oxidative Stress and Inflammatory Processes Affecting the Brains of Stroke-Prone Rats

  2010cites this paper
• Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome

  2010cites this paper
• Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity

  2010cites this paper
• 15d-PGJ2 Induces Apoptosis by Reactive Oxygen Species–mediated Inactivation of Akt in Leukemia and Colorectal Cancer Cells and Shows In vivo Antitumor Activity

  2009cites this paper
• Diet-induced obesity influences oocyte developmental competence via peroxisome proliferator-activated receptor gamma (PPARG)-mediated mechanisms.

  2009cites this paper
• Insulin signaling in chicken liver and muscle.

  2009cites this paper
• Secretion of atherogenic risk factor apolipoprotein B‐100 is increased by a potential mechanism of JNK/PKC‐mediated insulin resistance in liver cells

  2008influential citation
• Insulin Signaling in Adipocytes and the Role of Inflammation

  2008cites this paper
• PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility

  2008cites this paper
• Mécanismes de l’action antidiabétique des thiazolidinediones

  2008cites this paper
• Role of IRS-1 serine 307 phosphorylation and adiponectin in adipose tissue insulin resistance at late pregnancy

  2007cites this paper
• Role of insulin receptor substrate-1 serine 307 phosphorylation and adiponectin in adipose tissue insulin resistance in late pregnancy.

  2007cites this paper
• Myeloprotective effects of rosiglitazone, an insulin sensitizer, on 5-fluorouracil-induced toxicity

  2007cites this paper
• Adipose stress-sensing kinases: linking obesity to malfunction.

  2007cites this paper
• A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor- (cid:1) (PPAR (cid:1) ) Recruits PPAR (cid:1) -Coactivator-1 (cid:2) , Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro

  2006influential citation
• Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation

  2006cites this paper
• A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.

  2006cites this paper
• Mechanisms involved in the nutritional regulation of mRNA translation: features of the avian model

  2006cites this paper
• Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.

  2006cites this paper
• Rosiglitazone suppresses human lung carcinoma cell growth through PPARγ-dependent and PPARγ-independent signal pathways

  2006cites this paper
• A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Recruits PPARγ-Coactivator-1α, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro

  2006cites this paper
• Effect of rosiglitazone, an insulin sensitizer, on myelotoxicity caused by repeated doses of 5-fluorouracil.

  2006cites this paper
• A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor- (cid:1) (PPAR (cid:1) ) Recruits PPAR (cid:1) -Coactivator-1 (cid:2) , Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro

  2006influential citation
• The effect of PPARγ ligands on the adipose tissue in insulin resistance

  2005cites this paper
• The effect of PPARgamma ligands on the adipose tissue in insulin resistance.

  2005cites this paper
• The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance.

  2005cites this paper
• Modulation of insulin signalling by insulin sensitizers.

  2005cites this paper
• Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.

  2005cites this paper
• A Preadipocyte Differentiation Assay as a Method for Screening Potential Anti-Type II Diabetes Drugs from Herbal Extracts

  2005cites this paper
• The study of anti-metabolic syndrome effect of puerarin in vitro.

  2005cites this paper
• Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-α induction of p38 and p42/p44 mitogen-activated protein kinases

  2004cites this paper
• Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease*

  2004cites this paper
• TraitMap: an XML-based genetic-map database combining multigenic loci and biomolecular networks

  2004cites this paper